 SUNNYVALE, Calif., Jan. 19, 2021 PRNewswire -- Accuray Incorporated NASDAQ: ARAY announced today that data from a prospective, phase II trial of 338 women with low-risk breast cancer showed 98.8 percent had local disease control seven years after receiving once-daily accelerated... 